Literature DB >> 3945256

Microvascular deposition of complement membrane attack complex in dermatomyositis.

J T Kissel, J R Mendell, K W Rammohan.   

Abstract

We examined the role of the complement system in the pathogenesis of dermatomyositis. Using an antibody against the neoantigens of the terminal C5b-9 membrane attack complex, we performed immunocytochemical studies that localized this complex to the intramuscular microvasculature (arterioles and capillaries) of muscle biopsy specimens from 10 of 12 patients (83 percent) with childhood dermatomyositis and 5 of 19 patients (26 percent) with adult dermatomyositis. Fifty-two control specimens, including 14 from patients with polymyositis and 12 from patients with denervation atrophy (a condition known to be associated with necrotic capillaries), showed no deposition of membrane attack complex in the microvasculature. These findings indicate that the complement system is deposited, bound, and activated to completion within the intramuscular microvasculature of patients with dermatomyositis. In addition to providing further evidence for the presence of vasculopathy in dermatomyositis, these findings suggest a primary role for complement in mediating vessel injury in the disease, particularly in its childhood form.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945256     DOI: 10.1056/NEJM198602063140601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  87 in total

1.  A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.

Authors:  Lisa Christopher-Stine; Livia A Casciola-Rosen; Grace Hong; Tae Chung; Andrea M Corse; Andrew L Mammen
Journal:  Arthritis Rheum       Date:  2010-09

2.  Clinico-pathologic conference: case 6.

Authors:  Julien E Ghannoum; Nora A Odingo; Nathalie Provost
Journal:  Head Neck Pathol       Date:  2009-10-17

3.  Antibodies to endothelial cells in dermatomyositis: association with interstitial lung disease.

Authors:  R Cervera; G Ramírez; J Fernández-Solà; D D'Cruz; J Casademont; J M Grau; R A Asherson; M A Khamashta; A Urbano-Márquez; G R Hughes
Journal:  BMJ       Date:  1991-04-13

4.  Therapeutic advances and future prospects in immune-mediated inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

5.  Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders.

Authors:  Josep Dalmau; Luis Bataller
Journal:  Hematol Oncol Clin North Am       Date:  2006-12       Impact factor: 3.722

6.  Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology.

Authors:  Mohammed I Alhatou; John T Sladky; Omar Bagasra; Jonathan D Glass
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

Review 7.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

8.  High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.

Authors:  M Basta; M C Dalakas
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation.

Authors:  Yasuhiro Katsumata; William M Ridgway; Timothy Oriss; Xinyan Gu; David Chin; Yuehong Wu; Noreen Fertig; Tim Oury; Daniel Vandersteen; Paula Clemens; Carlos J Camacho; Andrew Weinberg; Dana P Ascherman
Journal:  J Autoimmun       Date:  2007 Sep-Nov       Impact factor: 7.094

10.  Paraneoplastic dermatomyositis as presentation of thymic carcinoma.

Authors:  Andrea Dell'Amore; Nizar Asadi; Guido Caroli; Giampiero Dolci; Alessandro Bini; Franco Stella
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.